Mural Oncology plc
CIK 0001971543
Revenue (TTM)
—
Q3 Nov 2025
Net Income (TTM)
−$116.58M
+38.0% YoY
Q3 Nov 2025
EPS Diluted (TTM)
−$6.79
+39.0% YoY
Q3 Nov 2025
Gross Margin
—
Q3 Nov 2025
Operating Margin
—
Q3 Nov 2025
Net Margin
—
Q3 Nov 2025
Free Cash Flow (TTM)
−$128.64M
Q3 Nov 2025
Cash
$58.87M
Q3 Nov 2025
Total Debt
—
Q3 Nov 2025
Shares Outstanding
17.34M sh
Q3 Nov 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.